James B. Nelson
CIK: 0001589502
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Co-Diagnostics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- May 23, 2026CODX
Co-Diagnostics, Inc.
Award(A)Direct1.7K shares- - May 23, 2026CODX
Co-Diagnostics, Inc.
Exercise(M)DirectRestricted Stock Unit
1.7K shares- - Nov 23, 2025CODX
Co-Diagnostics, Inc.
Award(A)Direct57.5K shares- - Nov 23, 2025CODX
Co-Diagnostics, Inc.
Exercise(M)DirectRestricted Stock Unit
57.5K shares- - Aug 13, 2025CODX
Co-Diagnostics, Inc.
Award(A)DirectRestricted Stock Units
125K shares- - May 23, 2025CODX
Co-Diagnostics, Inc.
Exercise(M)DirectRestricted Stock Unit
48.3K shares- - May 23, 2025CODX
Co-Diagnostics, Inc.
Award(A)Direct48.3K shares- - Nov 23, 2024CODX
Co-Diagnostics, Inc.
Exercise(M)DirectRestricted Stock Unit
48.3K shares- - Nov 23, 2024CODX
Co-Diagnostics, Inc.
Award(A)Direct48.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 23, 2026 | CODX Co-Diagnostics, Inc. | Award(A) | 1,695 | - | $0 | Direct |
| May 23, 2026 | CODX Co-Diagnostics, Inc. | Exercise(M) Restricted Stock Unit | 1,695 | - | - | Direct |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | Award(A) | 57,499 | - | - | Direct |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | Exercise(M) Restricted Stock Unit | 57,499 | - | - | Direct |
| Aug 13, 2025 | CODX Co-Diagnostics, Inc. | Award(A) Restricted Stock Units | 125,000 | - | - | Direct |
| May 23, 2025 | CODX Co-Diagnostics, Inc. | Exercise(M) Restricted Stock Unit | 48,334 | - | - | Direct |
| May 23, 2025 | CODX Co-Diagnostics, Inc. | Award(A) | 48,334 | - | - | Direct |
| Nov 23, 2024 | CODX Co-Diagnostics, Inc. | Exercise(M) Restricted Stock Unit | 48,333 | - | - | Direct |
| Nov 23, 2024 | CODX Co-Diagnostics, Inc. | Award(A) | 48,333 | - | $0 | Direct |
1-9 of 9 transactions
About NELSON JAMES B
NELSON JAMES B (SEC CIK 0001589502) files insider reports with the SEC as Director of Co-Diagnostics, Inc. (CODX).
Signal8 holds 5 ownership filings by NELSON JAMES B, all Form 4s, filed between Nov 25, 2024 and May 27, 2026. Those filings report 9 transactions, from Nov 23, 2024 to May 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on NELSON JAMES B's filings is in SALT LAKE CITY, UT.
Recent filings by NELSON JAMES B
- May 23, 2026: Grant or award of CODX shares (Form 4, code A).
- May 23, 2026: Option exercise of CODX derivative securities (Form 4, code M).
- Nov 23, 2025: Grant or award of CODX shares (Form 4, code A).
- Nov 23, 2025: Option exercise of CODX derivative securities (Form 4, code M).
- Aug 13, 2025: Grant or award of CODX derivative securities (Form 4, code A).
Other insiders filing for Co-Diagnostics, Inc. (CODX)
- Bohrer Daniel, EVP of Finance & Accounting
- Egan Dwight H, Chief Executive Officer
- Brown Brian Lee, Chief Financial Officer
- Abbott Richard David, President
- Murphy Edward L., Director
- SERBIN RICHARD S, Director